Zoetis (CHIX:ZOED) Cyclically Adjusted PS Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ZOED Zoetis Inc CHIX:ZOED
65 GF Score
Price €66.42
GF Value €168.31
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zoetis  (CHIX:ZOEd) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zoetis Cyclically Adjusted PS Ratio Related Terms


Zoetis Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Zoetis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zoetis Cyclically Adjusted PS Ratio Chart

Zoetis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.24 10.41 12.98 9.92 7.11

Zoetis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.78 9.06 8.34 7.11 6.48

CHIX:ZOED vs UTHR, VTRS, NBIX: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zoetis's Cyclically Adjusted PS Ratio falls into.


CHIX:ZOED
65GF Score
Zoetis Inc CHIX:ZOED
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zoetis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zoetis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Zoetis's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.632/330.2130*330.2130
=4.632

Current CPI (Mar. 2026) = 330.2130.

Zoetis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2.155 241.018 2.953
201609 2.221 241.428 3.038
201612 2.438 241.432 3.335
201703 2.324 243.801 3.148
201706 2.286 244.955 3.082
201709 2.295 246.819 3.070
201712 2.513 246.524 3.366
201803 2.262 249.554 2.993
201806 2.485 251.989 3.256
201809 2.611 252.439 3.415
201812 2.838 251.233 3.730
201903 2.665 254.202 3.462
201906 2.839 256.143 3.660
201909 2.987 256.759 3.842
201912 3.137 256.974 4.031
202003 2.898 258.115 3.707
202006 2.875 257.797 3.683
202009 3.169 260.280 4.020
202012 3.102 260.474 3.933
202103 3.289 264.877 4.100
202106 3.390 271.696 4.120
202109 3.551 274.310 4.275
202112 3.660 278.802 4.335
202203 3.804 287.504 4.369
202206 4.117 296.311 4.588
202209 4.310 296.808 4.795
202212 4.126 296.797 4.591
202303 4.021 301.836 4.399
202306 4.347 305.109 4.705
202309 4.368 307.789 4.686
202312 4.411 306.746 4.748
202403 4.391 312.332 4.642
202406 4.810 314.175 5.056
202409 4.744 315.301 4.968
202412 4.905 315.605 5.132
202503 4.538 319.799 4.686
202506 4.787 322.561 4.901
202509 4.614 324.800 4.691
202512 4.648 324.054 4.736
202603 4.632 330.213 4.632

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Zoetis (CHIX:ZOED) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of €66.42 is trading 60.5% below its estimated GF Value™ of €168.31. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for CHIX:ZOED:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €168.31 vs. price of €66.42 (60.5% below fair value)
  • GF Score™: 65/100

No single metric tells the full story. See the CHIX:ZOED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
65GF Score

Get the complete analysis for CHIX:ZOED

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.42
Price
€168.31
GF Value